AU6278300A - Tumor-associated antigen (r11) - Google Patents

Tumor-associated antigen (r11)

Info

Publication number
AU6278300A
AU6278300A AU62783/00A AU6278300A AU6278300A AU 6278300 A AU6278300 A AU 6278300A AU 62783/00 A AU62783/00 A AU 62783/00A AU 6278300 A AU6278300 A AU 6278300A AU 6278300 A AU6278300 A AU 6278300A
Authority
AU
Australia
Prior art keywords
tumor
associated antigen
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62783/00A
Other languages
English (en)
Inventor
Ulrich Koenig
Renate Konopitzky
Wolfgang Sommergruber
Thomas Woelfel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of AU6278300A publication Critical patent/AU6278300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU62783/00A 1999-08-04 2000-07-28 Tumor-associated antigen (r11) Abandoned AU6278300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19936563A DE19936563A1 (de) 1999-08-04 1999-08-04 Tumorassoziiertes Antigen
DE19936563 1999-08-04
PCT/EP2000/007338 WO2001011040A1 (de) 1999-08-04 2000-07-28 Tumorassoziiertes antigen (r11)

Publications (1)

Publication Number Publication Date
AU6278300A true AU6278300A (en) 2001-03-05

Family

ID=7917065

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62783/00A Abandoned AU6278300A (en) 1999-08-04 2000-07-28 Tumor-associated antigen (r11)

Country Status (9)

Country Link
EP (1) EP1206535A1 (es)
JP (1) JP2003506085A (es)
AU (1) AU6278300A (es)
CA (1) CA2383230A1 (es)
CO (1) CO5280153A1 (es)
DE (1) DE19936563A1 (es)
MX (1) MXPA02001137A (es)
UY (1) UY26266A1 (es)
WO (1) WO2001011040A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8258260B2 (en) 1970-02-11 2012-09-04 Immatics Biotechnologies Gmbh Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
US8212000B2 (en) 1970-02-11 2012-07-03 Immatics Biotechnologies Gmbh Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
US8211999B2 (en) 1970-02-11 2012-07-03 Immatics Biotechnologies Gmbh Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
JP2003093066A (ja) * 2001-09-21 2003-04-02 Univ Tokyo 癌細胞の増殖および細胞死を制御する方法
CA2469738A1 (en) 2001-11-07 2003-08-07 Mannkind Corporation Expression vectors encoding epitopes of target-associated antigens and methods for their design
DE10211088A1 (de) * 2002-03-13 2003-09-25 Ugur Sahin Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
DE10225144A1 (de) 2002-05-29 2003-12-18 Immatics Biotechnologies Gmbh An MHC-Moleküle bindende Tumor-assoziierte Peptide
US20050221350A1 (en) 2002-05-29 2005-10-06 Toni Weinschenk Method for identifying immunoreactive peptides
DE10341812A1 (de) * 2003-09-10 2005-04-07 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
DE102005041616B4 (de) * 2005-09-01 2011-03-17 Johannes-Gutenberg-Universität Mainz Melanom-assoziierte MHC Klasse I assoziierte Oligopeptide und für diese kodierende Polynukleotide und deren Verwendungen
DE602005005196T2 (de) 2005-09-05 2008-06-26 Immatics Biotechnologies Gmbh Tumor-assoziierte Peptide, welche an unterschiedliche menschliche Leukozytenantigene der Klasse II binden
EP2364366B1 (en) 2008-11-05 2014-01-08 MorphoSys AG Deconvolution method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999018206A2 (en) * 1997-10-08 1999-04-15 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Human cancer antigen ny eso-1/cag-3 and gene encoding same
JP2004507202A (ja) * 1999-03-31 2004-03-11 キュラジェン　コーポレイション ポリペプチドをコードするオープンリーディングフレームを含む核酸；「ｏｒｆｘ」

Also Published As

Publication number Publication date
MXPA02001137A (es) 2002-11-04
WO2001011040A1 (de) 2001-02-15
CO5280153A1 (es) 2003-05-30
DE19936563A1 (de) 2001-02-08
JP2003506085A (ja) 2003-02-18
UY26266A1 (es) 2001-01-31
CA2383230A1 (en) 2001-02-15
EP1206535A1 (de) 2002-05-22

Similar Documents

Publication Publication Date Title
AU1290001A (en) Antibodies
AU2002256895A1 (en) Anti-TRAIL-R antibodies
AU4935000A (en) Antibodies
AU2002351623A1 (en) Streptococcus antigens
AU2001282890A1 (en) Immunosensor
AU1951201A (en) Peptide antigens
AUPR395801A0 (en) Antibodies against cancer
AU2002365649A1 (en) Anti-dota antibody
AU2001290860A1 (en) Spas-1 cancer antigen
AU2002307438A1 (en) Cancer-testis antigens
AU5441000A (en) Human monoclonal antibody
AU2002349543A1 (en) Tumor antigens
AU7135500A (en) Slide latch
AU6278300A (en) Tumor-associated antigen (r11)
AU2977500A (en) Advanced antigen presentation platform
AU2948199A (en) Breast cancer antigen
AU3283500A (en) Tumor-associated antigen
AU2002236517A1 (en) Targetet retoviral vectors for cancer immunotherapy
AU7572198A (en) Tumor-associated antigen
AU5059700A (en) Transporting device
AU4924000A (en) Tumor-associated antigen (c42)
AU2452301A (en) Protein methylarginine-specific antibodies
AU4553100A (en) Tumour-associated antigen
AU2001261534A1 (en) The meca-79 antigen and related methods
AU7788600A (en) Colon-tumour-associated antigens

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase